NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹260 Cr | ₹300 Cr | ₹164 Cr | ₹64 Cr | ₹81 Cr |
What is the latest Profit After Tax of NEULAND LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹64 Cr |
| Mar2021 | ₹81 Cr |
How is Profit After Tax of NEULAND LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | -13.32 | |
| Mar2024 | ₹300 Cr | 83.51 | |
| Mar2023 | ₹164 Cr | 156.21 | |
| Mar2022 | ₹64 Cr | -20.85 | |
| Mar2021 | ₹81 Cr | - | |
Compare Profit After Tax of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,133.1 Cr | -0.7% | 11.2% | 59.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -0.7% |
11.2% |
59.2% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses